Personal digital assistant devices and medication error
个人数字助理设备和用药错误
基本信息
- 批准号:6528318
- 负责人:
- 金额:$ 33.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2004-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: Verbatim from the Applicant?s Abstract
The purpose of this study is to determine the impact of the use of personal
digital assistants (PDAs) by prescribers on potential medication errors in
primary care physicians office-based practices. The specific aims of this
study are to: 1) measure the occurrence of potential preventable medication
related errors in physician office-based practices; 2) assess physicians?
attitudes toward the PDAs to determine issues related to frequency of use,
ease of application to clinical situations, and confidence in the information
obtained from the handheld computer applications related to medications; 3)
identify barriers perceived by M.D.s to PDA use in practice and successful
strategies to overcome these barriers; 4) determine the extent to which the
frequency of potential medication related errors may be reduced by physicians
having improved access to pharmaceutical information needed at the point of
care through the use of personal digital assistant devices (PDAs); and 5)
determine the extent to which the frequency of potential medication related
errors may be reduced by physicians using the PDA as a prescription printing
device in office-based practice. The primary project is a prospective,
randomized, controlled trial of 40 physicians in 40 primary care office-based
practices to observe the impact of PDA use on potential prescriber medication
errors. A baseline potential medication error rate per physician will be
determined for all physicians. The physicians will then be randomized to two
groups: an intervention group and a control group. The intervention involves
training the physicians to use clinical information applications during the
prescribing process through the PDA and entering and printing the
prescriptions to a local printer via the PDA. The control group will conduct
their traditional prescribing practices throughout the study. Prior to
introducing the intervention, an analysis of the human factors and
environmental drivers on site in the physicians? offices will be conducted to
identify barriers to the technology, strategies to overcome these barriers,
and optimal incorporation of the technology and its applications into the
office environment. Instructional design methods will be used to prepare a
practice-based curriculum using case-simulation to teach the physician
prescribers in the intervention group how to engage in and systematically use
this process. A baseline assessment of their anticipated frequency of use,
ease of applications to clinical situations, and confidence in information
obtained will be studied. After use, these measures will be repeated by use
of survey instruments and in-depth interviews. The difference between the
control and intervention group mean potential error rate per physician will be
determined. Bivariate nonparametric statistics will be used to assess the
change in perception of the physicians regarding PDA use as a result of the
intervention. Expected outcomes are 1) to improve provider education to
reduce errors, 2) translate proven effective IT strategies into widespread
practice, and 3) build capacity to further reduce errors. This project will
generate new knowledge that can be used by providers, patients, payers, and
policymakers to determine the contribution of handheld PDAs to reduce medical
errors and improve patient safety in the primary care physician office-based
practice environment.
描述:申请人逐字摘录?S摘要
这项研究的目的是确定个人使用的影响
数字助理(PDA)由处方人员针对潜在的用药错误
初级保健医生办公室执业。这样做的具体目的是
研究的目的是:1)衡量潜在的可预防药物的发生率
医生办公室执业中的相关错误;2)评估医生?
对掌上电脑的态度,以确定与使用频率有关的问题,
易于应用于临床情况,并对信息有信心
从与药物有关的手持计算机应用程序获得;3)
确定医学博士在实践中和成功使用PDA时所感受到的障碍
克服这些障碍的战略;4)确定在多大程度上
医生可能会减少潜在的用药相关错误的频率
改进了对药物信息的访问,
通过使用个人数字助理设备(PDA)进行护理;以及5)
确定潜在用药的频率与
医生可以通过使用PDA作为处方打印来减少错误
基于办公室的实践中的设备。主要的项目是一个前瞻性的,
对40名初级保健办公室的40名医生进行的随机对照试验
观察PDA使用对潜在处方者用药影响的实践
错误。每位医生的基准潜在用药错误率将为
为所有内科医生下定决心。然后,医生将被随机分配到两名
分组:干预组和对照组。这项干预包括
培训医生在培训期间使用临床信息应用程序
通过掌上电脑开具处方流程并录入和打印
通过PDA将处方发送到本地打印机。对照组将进行
在整个研究过程中,他们的传统处方做法。在.之前
介绍了干预措施,分析了人为因素和
环保司机在医生的现场?办事处将被安排到
确定技术障碍、克服这些障碍的策略、
并将该技术及其应用最佳地结合到
办公环境。将使用教学设计方法准备一份
以实践为基础的课程--运用案例模拟教学
干预组处方人员如何参与和系统使用
这一过程。对其预期使用频率的基线评估,
临床应用的简便性和对信息的信心
将对所获得的信息进行研究。使用后,这些措施将重复使用
调查工具和深入访谈。两者之间的区别
控制组和干预组每个医生的平均潜在错误率将是
下定决心。将使用双变量非参数统计量来评估
医生对PDA使用的看法的变化
干预。预期结果是1)改善提供者教育,以
减少错误,2)将久经考验的有效IT战略转化为广泛的
实践,以及3)建设能力,以进一步减少错误。这个项目将
生成可供提供者、患者、付款人和
政策制定者将确定手持PDA对减少医疗费用的贡献
以初级保健医生办公室为基础的错误和改善患者安全
练习环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIMBERLY A GALT其他文献
KIMBERLY A GALT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIMBERLY A GALT', 18)}}的其他基金
Creighton Research Infrastruture Program to Achieve Sustainability Project
克赖顿研究基础设施计划以实现可持续发展项目
- 批准号:
7935462 - 财政年份:2009
- 资助金额:
$ 33.57万 - 项目类别:
Creighton Research Infrastruture Program to Achieve Sustainability Project
克赖顿研究基础设施计划以实现可持续发展项目
- 批准号:
8106424 - 财政年份:2009
- 资助金额:
$ 33.57万 - 项目类别:
Creighton Health Services Research Development Project
克赖顿健康服务研究开发项目
- 批准号:
7009728 - 财政年份:2006
- 资助金额:
$ 33.57万 - 项目类别:
Creighton Health Services Research Development Project
克赖顿健康服务研究开发项目
- 批准号:
7189117 - 财政年份:2006
- 资助金额:
$ 33.57万 - 项目类别:
Personal digital assistant devices and medication error
个人数字助理设备和用药错误
- 批准号:
6448717 - 财政年份:2001
- 资助金额:
$ 33.57万 - 项目类别:
Personal digital assistant devices and medication error
个人数字助理设备和用药错误
- 批准号:
6660403 - 财政年份:2001
- 资助金额:
$ 33.57万 - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 33.57万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Studentship
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 33.57万 - 项目类别:














{{item.name}}会员




